2018 Program

Topics embedded in the case studies and program include: strategy, revenue projections, market acceptance, crisis communications, team and board management, unwelcome suitors, unusual sources of funding and funding in the US, leadership, team building.

Monday, June 25

16:00 Arrival & Registration
17:00

Falconry & Networking

Powerscourt Lawn

18:30

Opening Events

Sally Gap Room

  • Drinks Reception
  • Welcome Remarks – Sara Jane Demy, Founder & CEO, Demy-Colton
  • Participant Self-Introductions
  • Fireside Chat: The Purposeful CEO: What Really Happened Behind the Scenes at Ablynx – the Bits You Won’t Hear Elsewhere!
    • Moderator: Stephanie Léouzon, Partner & Head of Europe, Torreya
    • Fireside Chatter: Edwin Moses, PhD, CEO, Ablynx NV
20:00

Dinner Reception at the Powerscourt

Sally Gap Room

Tuesday, June 26

07:15

Breakfast

Salon 3

08:30

Summit Overview and Rules of Engagement

Salon 2

08:45

Introduction of Minotaur Therapeutics (MNTZ) Case Study

Salon 2

Full Group Session

Synopsis: The CEO of Minotaur, who is planning a NASDAQ listing, receives new and disappointing information about the commercial prospects of its lead asset.

09:15

MNTZ Market Study Yields an Unwelcome Surprise: What Now?

  • Breakout Group 1
  • Breakout Group 2
10:00

MNTZ Debrief Team Recommendations – Reconvene and Readouts

Salon 2

10:30 Morning Break
10:45

MNTZ Crisis Continues – Unexpected Information

  • Breakout Group 1
  • Breakout Group 2
11:30

MNTZ Debrief Team Recommendations – Reconvene and Readouts

Salon 2

12:30

Networking Lunch

Sika Restaurant

13:45

Barbarians at MNTZs Gate – Are They Friendly? An Unwelcome Acquisition Offer

Salon 2

Full Group Discussion

15:00

MNTZ CEO Message and Plan to Move Forward

Salon 2

Full Group Discussion

16:00

Day 1 Wrap Up

Salon 2

17:00

CEO Summit Games

Secret Garden

19:30

Drinks Reception, Awards & Dinner

Sika Patio & Restaurant

Wednesday, June 27

07:30

Breakfast

Salon 3

08:45

Welcome Back & Overview for the Day

Salon 2

09:00

Introduction of Cellblock Therapeutics:

What is the Cost of New Money?

Salon 2

Full Group Discussion

Synopsis: Pushed to the edge in a challenging fundraising environment, the CEO of Cellblock accepts a major investment from a tech company. With this investment comes involvement from a board member who does not know the biotech space.

09:30

Cellblock Breakout Groups

  • Breakout Group 1
  • Breakout Group 2
10:15

Reconvene and Readout

Salon 2

Full Group Discussion

10:45 Break
11:00

Lead Asset Failure – Now What?

Salon 2

Full Group Discussion

12:00

Networking Lunch

Sika Restaurant

13:15

An Unguarded Conversation Among Friends: Hot Topics

Salon 2

Full Group Discussions or Breakouts

14:15

“Let’s Talk About NASDAQ and Accessing US Capital”

Salon 2

Full Group Discussion

  • Simon Moroney, DPhil, CEO, MorphoSys AG
  • Denise Scots-Knight, PhD, CEO, Mereo BioPharma Group plc
15:15 Closing Reception